Orchestra Biomed Hldgs Inc (OBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,302 | -22,986 | -10,940 | -33,608 | -23,858 |
| Depreciation Amortization | 324 | 217 | 107 | 385 | 279 |
| Accounts receivable | 10 | -75 | 20 | 25 | 25 |
| Other Working Capital | -3,191 | -3,804 | -4,416 | -451 | -545 |
| Other Operating Activity | 4,006 | 1,777 | 848 | 4,360 | 3,554 |
| Operating Cash Flow | $-35,153 | $-24,871 | $-14,381 | $-29,289 | $-20,545 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,383 | -35,349 | -43,494 | -63,531 | -208 |
| PPE Investments | -81 | -62 | -35 | -591 | -537 |
| Investing Cash Flow | $-22,464 | $-35,411 | $-43,529 | $-64,122 | $-745 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | 10,000 |
| Debt Repayment | N/A | N/A | N/A | -6,446 | -6,446 |
| Common Stock Issued | 101 | 97 | 11 | 110,030 | 110,030 |
| Common Stock Repurchased | N/A | N/A | N/A | -10 | N/A |
| Other Financing Activity | 56,810 | 56,810 | 56,810 | -10,317 | -5,237 |
| Financing Cash Flow | $56,911 | $56,907 | $56,821 | $103,257 | $108,347 |
| Beginning Cash Position | 19,784 | 19,784 | 19,784 | 9,938 | 9,938 |
| End Cash Position | 19,078 | 16,409 | 18,695 | 19,784 | 96,995 |
| Net Cash Flow | $-706 | $-3,375 | $-1,089 | $9,846 | $87,057 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,153 | -24,871 | -14,381 | -29,289 | -20,545 |
| Capital Expenditure | -81 | -62 | -35 | -591 | -537 |
| Free Cash Flow | -35,234 | -24,933 | -14,416 | -29,880 | -21,082 |